Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DC26084 LE-135 Featured

LE135 is a retinoid acid receptor antagonist, produces pain through direct activation of TRP channels.

155877-83-1
DC22495 Lenampicillin hydrochloride

An efficient prodrug of ampicillin with enhanced absorption and decreased side effects..

80734-02-7
DC24168 (R)-(-)-Ibuprofen Featured

An enantiomer of Ibuprofen that is generally not considered a COX inhibitor and is instead thought to be involved in pathways of lipid metabolism as it is incorporated into triglycerides along with fatty acids.

51146-57-7
DC22361 (S)-(+)-Ibuprofen

An enantiomer of Ibuprofen that more potently inhibits COX activity, thromboxane formation, and platelet aggregation than the (R)-form.

51146-56-6
DC24138 Synaptamide

An endogenous DHA metabolite that promotes neurite growth, synaptogenesis, and synaptic function both in vitro and in vivo.

162758-94-3
DC11747 Iperoxo

Iperoxo is a superagonist of the muscarinic acetylcholine receptors and an OxotremorineM analog.

247079-84-1
DC23324 C-1311 dihydrochloride

An imidazoacridinone analogue with potent in vivo antitumour activity, inhibits the catalytic activity of Topoisomerase II.

138154-55-9
DC25076 Imazamox

An imidazolinone herbicide that effectively controls a broad spectrum of weed species..

114311-32-9
DC23914 Thymalfasin Featured

An immunoactive peptide that has been shown to inhibit cell proliferation and induce apoptosis in human leukemia, non-small cell lung cancer, melanoma, and other human cancers.

62304-98-7
DC22995 IRES-J007 Featured

IRES-J007 ia an improved IRES inhibitor that blocks IRES-hnRNP A1 binding; binds to a small pocket structure within the RRM-containing fragment of hnRNP A1 (UP1 fragment), inhibits cyclin D1 and c-MYC IRES activity to a greater extent compared with C11 (IRES-C11); significantly reduces tumor growth of GBM xenografts in mice, and markedly reduces the mRNA translational state of cyclin D1 and c-MYC transcripts combined with PP242.

155514-72-0
DC22542 Roflumilast Impurity E

An impurity of Roflumilast, which is a selective and long-acting inhibitor of PDE-4 with IC50 value of 0.8 nM..

1391052-76-8
DC20988 Indirubin E804

An indirubin derivative that potently blocks constitutive STAT3 signaling in human breast and prostate cancer cells, directly inhibits Src kinase activity (IC50=0.43 uM) in vitro.

854171-35-0
DC22998 MIND4-17

An inducer of NRF2 that selectively activates NRF2 signaling with CD value (The concentration that doubles the specific activity) of 0.18 uM.

345989-24-4
DC23993 Aldose reductase-IN-1

An inhibitor of aldose reductase with IC50 of 28.9 pM.

1355612-71-3
DC22549 KDM5A-IN-1

An inhibitor of histone demethylase..

1905481-36-8
DC6311 Pomalidomide Featured

An inhibitor of LPS-induced TNFαrelease.Pomalidomide is thalidomide derivative that displays inhibition of LPS-induced TNFα release. Shows immunomodulator and anticancer effects.

19171-19-8
DC23937 SIBA

An inhibitor of the IMP-selective cytosolic 5'-nucleotidase (IC50=2-6 mM).

35899-54-8
DC22360 Valifenalate

An insecticide agent that is approved for application on high-value crops such as grapes, tomatoes and other vegetables..

283159-90-0
DC24195 Benoxafos

An insecticide agent..

16759-59-4
DC24177 Mitiglinide calcium hydrate Featured

An insulin secretion stimulator by closing the ATP-sensitive potassium KATP channels in pancreatic β cells.

207844-01-7
DC24164 Proparacaine hydrochloride

An irreversible local anesthetic.

5875-06-9
DC11640 PK-11195 Featured

PK 11195 is a ligand of translocator protein. It targets Leishmania chemotherapy (IC50s of 14.2 μM, 8.2 μM, 3.5 μM for L. amazonensis, L. major and L. braziliensis, respectively).

85532-75-8
Page 82 / Total 1558 FirstPrevNextLastGoto